Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizoaffective”

758 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 758 results

Large-scale testing (Phase 3)Study completedNCT00714818
What this trial is testing

Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental Illness

Who this might be right for
SchizophreniaBipolar DisorderSchizoaffective Disorder
University of British Columbia 13
Post-approval studies (Phase 4)Study completedNCT00253110
What this trial is testing

A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Janssen, LP 396
Not applicableStudy completedNCT07673718
What this trial is testing

Α-N-acetylgalactosaminidase in Schizoaffective Disorder

Who this might be right for
Schizoaffective Disorder
Elazığ Mental Health and Diseases Hospital 93
Not applicableStudy completedNCT04874974
What this trial is testing

Feasibility of a Novel Process-based Treatment for Patients With Psychosis

Who this might be right for
SchizophreniaSchizotypal DisorderDelusional Disorder+10 more
Max-Planck-Institute of Psychiatry 37
Post-approval studies (Phase 4)Study completedNCT00044187
What this trial is testing

The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder

Who this might be right for
SchizophreniaPsychotic DisordersBipolar Disorder
Eli Lilly and Company 130
Post-approval studies (Phase 4)Study completedNCT01136772
What this trial is testing

A Comparison of Long-acting Injectable Medications for Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
New York State Psychiatric Institute 311
Testing effectiveness (Phase 2)Study completedNCT01400477
What this trial is testing

Nicotinic Receptors and Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
University of Colorado, Denver 97
Not applicableStudy completedNCT02782442
What this trial is testing

Cognitive Training Delivered Remotely to Individuals With Psychosis (ROAM)

Who this might be right for
TreatmentActive ControlSchizophrenia+7 more
University of Minnesota 109
Early research (Phase 1)Study completedNCT02567370
What this trial is testing

Single-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581

Who this might be right for
Schizophrenia or Schizoaffective Disorder
Amgen 70
Testing effectiveness (Phase 2)WithdrawnNCT02197286
What this trial is testing

Targeted Vitamin D Treatment of Schizophrenia-Associated Hyperprolinemia

Who this might be right for
SchizophreniaSchizoaffective Disorder
NYU Langone Health
Not applicableStudy completedNCT02566057
What this trial is testing

Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+2 more
Northwell Health 36
Post-approval studies (Phase 4)Study completedNCT00320736
What this trial is testing

Galantamine for Cognition in People With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
North Suffolk Mental Health Association 20
Not applicableStudy completedNCT03179696
What this trial is testing

Mobile-Assisted Cognitive Behavior Therapy for Negative Symptoms in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Eric Granholm 31
Testing effectiveness (Phase 2)Study completedNCT03510741
What this trial is testing

Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder.

Who this might be right for
SchizophreniaSchizophreniform DisordersSchizoaffective Disorder
Pakistan Institute of Living and Learning 64
Not applicableStudy completedNCT04497857
What this trial is testing

Academic-Community EPINET (AC-EPINET)

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorders+2 more
Indiana University 74
Not applicableStudy completedNCT03050853
What this trial is testing

The Appeal and Impact of E-cigarettes in Smokers With SMI

Who this might be right for
Tobacco DependenceSchizophreniaBipolar Disorder+1 more
Dartmouth-Hitchcock Medical Center 240
Early research (Phase 1)Study completedNCT00796081
What this trial is testing

A Safety and Pharmacokinetic Study of ER OROS Paliperidone in Pediatric Patients With Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 25
Testing effectiveness (Phase 2)Ended earlyNCT00917293
What this trial is testing

Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Medicure 53
Not applicableActive Not RecruitingNCT05877716
What this trial is testing

EPI-MINN: Targeting Cognition and Motivation - National

Who this might be right for
PsychosisPsychosis Nos/OtherSchizophrenia+8 more
University of Minnesota 55
Post-approval studies (Phase 4)WithdrawnNCT00672464
What this trial is testing

Cardio Risk of Acute Schizophrenia Olanzapine Duke

Who this might be right for
SchizophreniaSchizoaffective Disorder
Duke University
Next Page